國泰航空上半年大幅扭虧為盈 可載客量有望於年底達至疫情前70%
格隆匯8月9日丨國泰航空公佈2023年中期業績,收益435.93億港元,同比增長135%;國泰航空股東應占溢利42.68億港元,較去年同期的虧損49.99億港元大幅扭虧為盈。上半年客運收益250.13億港元,同比增長1109.5%。集團在2023年一直維持經營正現金流,於2023年6月30日可動用的無限制用途流動資金餘額為289億港元。展望未來,集團的可載客量有望於2023年底達至疫情前70%,服務八十個航點,並有信心於2024年底達至疫情前100%;預計業務於2023年下半年會保持穩健表現,並隨着踏入傳統旺季,第三季度末的載貨噸數將有所改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.